Pharmacokinetics of recombinant activated factor VII (rFVIIa).
about
Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseasesHuman recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseasesThe use of recombinant activated coagulation factor VII for spine surgeryBio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)Continuous infusion of coagulation factor products.Pharmacological approaches to reducing allogeneic blood exposure.Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleedingHome management of haemophilia.The potential use of recombinant activated factor VII in trauma and surgery.Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors.Recombinant Factor VIIa: clinical applications for an intravenous hemostatic agent with broad-spectrum potential.Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions.The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage.A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.The pharmacokinetics of coagulation factors.Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVIIEndothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium.Recombinant activated factor VII following pediatric cardiac surgery.Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin.Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog.Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort study.Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients.Some technical considerations of open thoracoabdominal aortic aneurysm repair in a transition country.A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).Factor VIIa binding and internalization in hepatocytesInfluence of endothelial cell protein C receptor on plasma clearance of factor VIIa.Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.Recombinant activated factor VII as treatment for uncontrolled mucosal haemorrhage.Phase I, randomized, double-blind, placebo-controlled, single-dose escalation study of the recombinant factor VIIa variant BAY 86-6150 in hemophilia.Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.Recombinant activated factor VII.Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa aRecombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.Effect of glycoPEGylation on factor VIIa binding and internalization.
P2860
Q24201303-061EB20A-CF5F-4F36-A566-334CAB52E00EQ24246238-F6BC77DA-FF91-4136-A0BA-696AF5634BEBQ33360946-3D4AE78A-AB44-450D-87CC-611AF15CA5D2Q33768400-7172ACC7-2163-42CB-9E2C-C2881B5A1A65Q34615620-DBF83223-0B14-4DDE-AACA-E2E6C7C7F33DQ35050993-D4729DEF-6683-435C-98D1-726BAECE0B9BQ35544621-59118FCC-794B-4F9F-9680-DDC1ADE8E59BQ35666730-7D3C1A0E-0C9A-403D-9F47-D1CD209FE99DQ35760073-103E357E-3E35-493E-8A4F-D70F4186FB03Q35771690-2B51192C-A8F1-4F57-A52F-EF7E9E90E630Q35879063-4E4B8972-4A81-4821-BE66-F516D92118C1Q36263592-4032FA81-9157-477B-8817-4104558334A5Q36349573-CAA69FB4-3A32-4EFF-B7EA-804689B6579BQ36462093-270E8ABF-7354-4844-97FA-C19AA461F85EQ36473015-2934BAD9-CAF7-423E-A278-4CDCD98F31EAQ36547796-FD8EA9AD-4C5B-4290-A8A4-7EBAB9A9E2FBQ36991863-AAB206AF-DEEB-4E3F-888F-2CF2824E231CQ37383921-63C36774-C742-4CB5-9500-BD7CCA31D6B7Q37570030-EF14D206-ADBA-4CD0-BF16-CAAA71CC8732Q37586365-702383F9-7635-41DF-A97A-267E0B242343Q37649896-3ECE98F6-E428-4279-8B20-E2BBBFDE48DCQ37778292-E3748EB3-C255-40B2-8284-DACD0E28AD49Q37899679-F5D42A12-C3B5-4F5D-AAAD-1D7FB457BC8DQ39392420-169C75C4-ADF0-4A88-8B74-66D571FF520DQ40367398-60055569-D0E0-45D5-BA2B-3DD65A827362Q41856136-B68AADA9-1296-44DF-8F7E-A8EA5146DB78Q42112270-73D1ABEC-9AD5-4D0E-A4EC-9FC2C77A3423Q42783616-4007F038-D89D-4928-897E-6D5A9AC07016Q44355510-44B08B79-BB62-4306-A603-A0C0ADBD393FQ45855862-48444497-EB3E-4F6B-BD9D-E50DA387AC91Q45861831-203AB6BB-121F-42B1-83E1-B69512DBCF7FQ45863098-9FE298DA-9DF3-4C8A-99F4-8C5D17B113ACQ45869094-6DEACAA9-507C-4FA1-A1C3-344199608B68Q45870380-9555F07F-C996-4274-A7DC-00694524C91BQ45874642-BAE21C4A-A42A-4C49-9E71-18DC201DE228Q45889137-2C87DF2F-84F8-4338-9675-092D0FD696CF
P2860
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
@ast
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
@en
Pharmacokinetics of recombinant activated factor VII
@nl
type
label
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
@ast
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
@en
Pharmacokinetics of recombinant activated factor VII
@nl
prefLabel
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
@ast
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
@en
Pharmacokinetics of recombinant activated factor VII
@nl
P356
P1476
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
@en
P2093
E Erhardtsen
P304
P356
10.1055/S-2000-8457
P577
2000-01-01T00:00:00Z